{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:31Z","timestamp":1787032771329,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,3]]},"DOI":"10.7759\/cureus.81664","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T20:27:25Z","timestamp":1743712045000},"source":"Crossref","is-referenced-by-count":2,"title":["Hydroxychloroquine-Induced Hepatotoxicity in Systemic Lupus Erythematous: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Dana","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier E","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020, 16:155-66. 10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105143","article-title":"Hydroxychloroquine in systemic and autoimmune diseases: where are we now?","volume":"88","author":"Dima A","year":"2021","unstructured":"Dima A, Jurcut C, Arnaud L. Hydroxychloroquine in systemic and autoimmune diseases: where are we now?. Joint Bone Spine. 2021, 88:105143. 10.1016\/j.jbspin.2021.105143","journal-title":"Joint Bone Spine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.08.016","article-title":"Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment","volume":"30","author":"Yogasundaram H","year":"2014","unstructured":"Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014, 30:1706-15. 10.1016\/j.cjca.2014.08.016","journal-title":"Can J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima A","year":"2022","unstructured":"Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 2022, 14:1759720X211073001. 10.1177\/1759720X211073001","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(06)07","article-title":"Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"68","author":"Silva JC","year":"2013","unstructured":"Silva JC, Mariz HA, Rocha LF Jr, et al.. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (Sao Paulo). 2013, 68:766-71. 10.6061\/clinics\/2013(06)07","journal-title":"Clinics (Sao Paulo)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi I","year":"2012","unstructured":"Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012, 42:145-53. 10.1007\/s12016-010-8243-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin AJ","year":"1994","unstructured":"Makin AJ, Wendon J, Fitt S, Portmann BC, Williams R. Fulminant hepatic failure secondary to hydroxychloroquine. Gut. 1994, 35:569-70. 10.1136\/gut.35.4.569","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318768884","article-title":"The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda","volume":"27","author":"Sunkara B","year":"2018","unstructured":"Sunkara B, Roofeh D, Silver S, Pearson TL, Ettel M, McCune WJ. The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Lupus. 2018, 27:1383-6. 10.1177\/0961203318768884","journal-title":"Lupus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0218-1","article-title":"Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease","volume":"26","author":"Giner Galva\u00f1 V","year":"2007","unstructured":"Giner Galva\u00f1 V, Oltra MR, Rueda D, Esteban MJ, Red\u00f3n J. Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease. Clin Rheumatol. 2007, 26:971-2. 10.1007\/s10067-006-0218-1","journal-title":"Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314561667","article-title":"Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report","volume":"24","author":"Abdel Galil SM","year":"2015","unstructured":"Abdel Galil SM. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report. Lupus. 2015, 24:638-40. 10.1177\/0961203314561667","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0276","article-title":"Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19","volume":"102","author":"Falc\u00e3o MB","year":"2020","unstructured":"Falc\u00e3o MB, Pamplona de G\u00f3es Cavalcanti L, Filgueiras Filho NM, Antunes de Brito CA. Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19. Am J Trop Med Hyg. 2020, 102:1214-6. 10.4269\/ajtmh.20-0276","journal-title":"Am J Trop Med Hyg"},{"key":"ref12","article-title":"A hydroxychloroquine-related acute liver failure case and review of the literature","volume":"16","author":"Gisi K","year":"2021","unstructured":"Gisi K, Ispiroglu M, Kilinc E. A hydroxychloroquine-related acute liver failure case and review of the literature. J Clin Toxicol. 2021, 16:1-4.","journal-title":"J Clin Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000598756.33512.43","article-title":"hydroxychloroquine-induced acute liver injury","volume":"114","author":"Cheema B","year":"2019","unstructured":"Cheema B, Triplett D, Krishnamurthy P. hydroxychloroquine-induced acute liver injury. Am J Gastroenterol. 2019, 114:1286. 10.14309\/01.ajg.0000598756.33512.43","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk EL","year":"2020","unstructured":"Nirk EL, Reggiori F, Mauthe M. Hydroxychloroquine in rheumatic autoimmune disorders and beyond. EMBO Mol Med. 2020, 12:e12476. 10.15252\/emmm.202012476","journal-title":"EMBO Mol Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04868-6","article-title":"Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities","volume":"41","author":"Muller R","year":"2021","unstructured":"Muller R. Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatol Int. 2021, 41:1189-202. 10.1007\/s00296-021-04868-6","journal-title":"Rheumatol Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2016.076","article-title":"Concurrent inflammation augments antimalarial drugs-induced liver injury in rats","volume":"6","author":"Niknahad H","year":"2016","unstructured":"Niknahad H, Heidari R, Firuzi R, et al.. Concurrent inflammation augments antimalarial drugs-induced liver injury in rats. Adv Pharm Bull. 2016, 6:617-25. 10.15171\/apb.2016.076","journal-title":"Adv Pharm Bull"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2000.020005366.x","article-title":"The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver","volume":"20","author":"Matsumoto T","year":"2000","unstructured":"Matsumoto T, Kobayashi S, Shimizu H, et al.. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver. 2000, 20:366-73. 10.1034\/j.1600-0676.2000.020005366.x","journal-title":"Liver"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)80221-6","article-title":"Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P","volume":"99","author":"Arnett FC","year":"1995","unstructured":"Arnett FC, Reichlin M. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med. 1995, 99:465-72. 10.1016\/s0002-9343(99)80221-6","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080336","article-title":"Liver involvement in systemic lupus erythematosus: case review of 40 patients","volume":"35","author":"Chowdhary VR","year":"2008","unstructured":"Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol. 2008, 35:2159-64. 10.3899\/jrheum.080336","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278853-hydroxychloroquine-induced-hepatotoxicity-in-systemic-lupus-erythematous-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T20:27:26Z","timestamp":1743712046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278853-hydroxychloroquine-induced-hepatotoxicity-in-systemic-lupus-erythematous-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.81664","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}